Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, COPD and Dupixent
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler therapy, according to a press release from manufacturer Regeneron.
FDA approves Dupixent for adults with poorly controlled COPD
The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of immune cells.
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
15h
Regeneron’s Growth Prospects Bolstered by Dupixent Approval and Promising Oncology Pipeline
Regeneron (REGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan ...
19h
Eli Lilly: Ebglyss To Challenge Dupixent In Atopic Dermatitis
Eli Lilly's Ebglyss gains FDA approval for atopic dermatitis treatment, poised to rival Dupixent with strong performance in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Dockworkers launch strike
Pete Rose dies at 83
Helene wreaks havoc
NBA Hall of Famer dies
Medical records breached
Tony-winning star dies
Explosive devices found
Wausau drop box replaced
CA bans legacy admissions
More troops to Middle East
Settlement checks delayed
Hand count rule challenged
Lose 'superhero' trademark
Asylum restrictions extended
NH voter ID law challenged
Mich. nuclear plant to restart
194K Jeep SUVs recalled
To lay off 2,900 employees
SpaceX Falcon 9 grounded
Sells stake in DirecTV
'Sing Sing' actor exonerated
To sue Google, Samsung
Settles data breach cases
Signals more rate cuts
Red Sox honor radio voice
Israel announces operation
Feedback